Here's Why Cigna (CI) is a Strong Growth Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Stock Taper 
CI
$281.03
▲ UP 0.90% (2.52)
KEY STATISTICS
Market Cap$74.17 B
52w High$312.18
52w Low$239.51
Dividend Yield2.16%
FrequencyQuarterly
P/E9.09
Volume1.51M
Shares Out.264.24M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Brian C. Evanko
COMPENSATION 2026
Salary$1,600,000
Stock Awards$13,929,161
Incentive Plan Pay$3,200,000
All Other Comp.$639,392
Total$22,866,134
ABOUT
SECTOR
Healthcare
WENT PUBLIC
March 31, 1982
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
66,685
PRICE TARGET
Target High$400.00
Target Low$302.00
Target Median$340.00
Target Consensus$342.08
UPCOMING EARNINGS
DateOct 29, 2026
DayThursday
Rev. Est.$72.65B
OCT
29
THU
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2007-06-05 | Forward | 3:1 |
| 1998-05-18 | Forward | 3:1 |
ETFS HOLDING THIS STOCK
ETFS HOLDING
1,090
LISTED HERE
10
RANKED BY POSITION SIZE
INSTITUTIONAL OWNERSHIP
SHARES OWNED
100.00%
HOLDERS
2,421
TOP 8 OF 2,421 · RANKED BY POSITION SIZE
PRICE
$281.03 ▲ UP 0.90% (+$2.52)About Cigna Corporation
https://www.thecignagroup.com ↗The Cigna Group offers insurance and health services—including medical, pharmacy, behavioral health, and benefits management—to individuals, employers, and organizations in the U.S. and internationally through various segments and distribution cha...
INDUSTRY
Medical - Healthcare Plans
A SERVICE CIGNA CORPORATION IS KNOWN FOR
Clearity by Cigna Healthcare
Cigna's copayment-only health insurance plan eliminates deductibles and coinsurance, offering predictable costs and leveraging AI tools for transparency and simplicity in healthcare.
Cigna in 2025
SENTIMENT: → NEUTRAL
LEADERSHIP · MARCH 2025
Cigna Overhauls Executive Leadership to Accelerate Growth Strategy, Appointing New President & COO and CFO
In a significant strategic move, Cigna Group announced a major leadership shuffle in March 2025, appointing Brian Evanko as the new President and Chief Operating Officer and Ann Dennison as Executive Vice President and Chief Financial Officer. This reorganization was aimed at accelerating the company's growth strategy and sharpening its focus on customers and patients. The announcement also included the departure of Eric Palmer, the President and CEO of Evernorth Health Services, a key business segment.
DIVESTITURE · Q1 2025 · COMPLETED
Cigna Divests Medicare Advantage Business for $3.7 Billion to Sharpen Focus on Evernorth and Cigna Healthcare
In a major strategic pivot, Cigna is divesting its Medicare Advantage business to Health Care Service Corporation (HCSC). This move is intended to allow the company to concentrate its resources on the growth of its Evernorth Health Services and Cigna Healthcare segments, marking a deliberate shift away from the government programs market.
Latest News
EARLIER COVERAGE
Cigna Healthcare Introduces Health Sense To Connect Guidance, Benefits and Clinical Support Around Each Person, Improving Affordability and Outcomes
By connecting information about each person's health, care and coverage, Health Sense℠ helps people receive continuous personalized support, make informed decisions and act sooner Projected to reduce inefficient health care spending by 10% by 2030, improving affordability for employers and customers alike. Watch a demonstration of the new Health Sense customer experience.
Cigna: Deeply Undervalued With Expected Double-Digit EPS Growth Ahead
Cigna is rated a 'Strong Buy' for its compelling value, robust earnings growth, and capital returns at a forward P/E of 8.9x. CI posted strong Q2 2026 results, raised full-year EPS guidance, and targets 10–14% annual EPS growth through 2030, driven by AI and specialty pharmacy. CI's asset-light model, expanding specialty pharma presence, and aggressive share buybacks support high-teens total return potential annually.
The Cigna Group (CI) Analyst/Investor Day Transcript
The Cigna Group (CI) Analyst/Investor Day Transcript
RATINGS SNAPSHOT
Overall rating: A-
Discounted Cash Flow5
Return On Equity4
Return On Assets5
Debt To Equity1
Price To Earnings3
Price To Book3
Overall Score4
MOST RECENT ANALYST GRADES
GRADE SUMMARY
BUY 5
OVERWEIGHT 4
OUTPERFORM 4
HOLD 2
EQUAL WEIGHT 2
17 GRADES IN THE LAST 12 MONTHS
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 UNH | $372.60 | COMPARE |
 CVS | $88.15 | COMPARE |
 ELV | $403.25 | COMPARE |
 REGN | $731.78 | COMPARE |
 COR | $314.22 | COMPARE |
 CAH | $233.28 | COMPARE |
 BDX | $181.68 | COMPARE |
 HUM | $386.54 | COMPARE |
TRADES BY CONGRESS
SENATE TRADES
Alan Armstrong
Purchase
2026-03-27
HOUSE TRADES
Jared Moskowitz
Sale (Full)
2026-03-23
Gilbert Cisneros
Sale (Full)
2026-03-13
Gilbert Ray Cisneros
Sale (Full)
2026-03-13
INSIDER TRADES
★
OFFICER: SEE REMARKS
Neville Everett
Sale · 617 shares
2026-09-03
★
OFFICER: SEE REMARKS
Evanko Brian C
Purchase · 6.7K shares
2026-09-01
★
OFFICER: SEE REMARKS
Evanko Brian C
Purchase · 3.1K shares
2026-09-01
★
DIRECTOR
Kurian George
Purchase · 108 shares
2026-08-31